Blog
The FCA’s Enforcement Watch 2 and what it means for the financial services industry
James Alleyne
27 February 2024
Sodium Valproate – the future of claims and compensation
Sodium valproate (brand names include Epilim and Depakote) is a drug to treat epilepsy, bipolar disorder and migraines which, if taken in pregnancy, is associated with a significant risk of birth defects and developmental disorders often known as Fetal Valproate Syndrome (FVS).
31 January 2024
Failures in maternity care – what is really going on?
As the evidence of failing maternity services appears to be mounting, the Government is now pledging to prioritise improvements to maternity care as part of it’s womens health strategy for 2024.
14 November 2023
Vitamin K for newborns – the simple treatment that should never be neglected
As a lawyer specialising in claims for babies who suffer severe injuries at birth and in the neonatal period, I am extremely saddened that cases are still coming to light where babies are not given vitamin K following birth. Errors such as those highlighted in the recent inquest into the death of seven-week-old William Moris-Patto - where his medical record erroneously stated he had been given the supplement when in fact it had not been administered - are extremely concerning.
19 September 2023
Birth Injury Claims: Hypoxic Ischaemic Encephalopathy
‘One of the most devastating complications that can result from medical mismanagement during labour and delivery is hypoxic ischaemic encephalopathy’ (K McCombe and D G Bogod).
Hypoxic Ischaemic Encephalopathy (HIE) is a term used to describe brain damage caused by a lack of oxygen (hypoxia) and / or a diminished amount of blood reaching a baby’s brain. HIE can occur during pregnancy, birth or shortly thereafter.
22 August 2023
Assessing newborn babies – some processes are ‘not fit-for-purpose’ for Black, Asian and ethnic minorities
Recent reports from the NHS Race and Health Observatory (an independent body created to examine ethnic inequalities), and the Government’s Healthcare Safety Investigation Branch (HSIB) highlight that ethnic minority babies are at a greater risk of inaccurate assessments, late diagnosis of conditions and poorer outcomes than white babies.
